The outcome people hope for from retinitis pigmentosa stem cell treatment depends heavily on how far the disease has already advanced. A person with early changes and a patient with a very small remaining field are in different positions, and good counselling begins by saying so plainly.
This page looks at stem cell treatment in India through the stages of RP, and explains how results are measured rather than judged by impression alone.

Associate Professor, Vitreo-Retina Surgeon. 10+ Years Experience

Senior Consultant Ophthalmologist & Eye Surgeon· 26+ yrs experience

Consultant Ophthalmologist & Eye Surgeon, MD, DO .16+ Years Experience
For early and middle stages, the goal usually discussed is to slow progression and preserve functional vision. For advanced stages, the focus is more cautious: the team assesses whether any responsive tissue remains and pairs any treatment with low-vision support. In every stage, patients are told clearly that responses vary and cannot be promised.
“Yes. Because the treatment supports surviving retinal cells, patients with more of them remaining are generally in a better position to be assessed for benefit.”
”
Yes, a full evaluation can still be done to see whether any measurable retinal response remains, and to plan low-vision support in any case.”
“By repeating visual fields, ERG, OCT and acuity at scheduled intervals and comparing them with the baseline taken before treatment.”
“This varies. Some patients first notice differences in everyday tasks while others do not, and formal tests at review visits give a more reliable picture than impressions.”
